BASELINE CHARACTERISTICS OF PATIENTS ENROLLED IN THE DISCOVER CKD PROSPECTIVE STUDY

Chronic Kidney Disease, Hypertension, Diabetes and CVD

Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications

 

 

 

 

Pollock, C.(1)*;Jesus Carrero, J.(2);Kanda, E.(3);Ofori-Asenso, R.(4);Chen, H.(5);Garcia Sanchez, J.J.(6);Pecoits-Filho, R.(7);Fishbane, S.(8);Lam, C.(9);Kashihara, N.(3);Wheeler, D.(10);

(1)Kolling Institute- University Of Sydney, Royal North Shore Hospital, Sydney, Australia;(2)Karolinska Institutet, Department Of Medical Epidemiology And Biostatistics, Solna, Sweden;(3)Kawasaki Medical School, Nephrology, Kurashiki, Japan;(4)Biopharmaceuticals Medical- Astrazeneca, Cardiovascular- Renal- Metabolism Epidemiology, Cambridge, United Kingdom;(5)Biopharmaceuticals Medical- Astrazeneca, Medical And Payer Evidence Statistics, Gaithersburg, United States;(6)Biopharmaceuticals Medical- Astrazeneca, Global Market Access And Pricing, Cambridge, United Kingdom;(7)Pontifical Catholic University Of Parana Arbor Research Collaborative For Health, School Of Medicine, Curitiba, Brazil;(8)Zucker School Of Medicine, Division Of Nephrology, Hempstead, United States;(9)National Heart Centre- Singapore- Duke-Nus Medical School- Singapore, Department Of Cardiology, Department Of Cardiology, Singapore;(10)University College London, Department Of Renal Medicine, London, United Kingdom;

https://storage.unitedwebnetwork.com/files/1041/c730ee904bb6d06278596221e7f7855b.pdf